Tropism of human pegivirus (Formerly known as GB virus C/hepatitis G virus) and host immunomodulation: Insights into a highly successful viral infection

Journal of General Virology

Volumn 96, Issue 7, 2015, Pages 1521-1532

  Chivero, Ernest T ^a   Stapleton, Jack T ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; CELL INTERACTION; HEMATOPOIETIC CELL; HEPATITIS C VIRUS; HEPATITIS G VIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; COMPLICATION; EXOSOME; FLAVIVIRIDAE INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MONONUCLEAR CELL; MORTALITY; PHYSIOLOGY; VIRAL TROPISM; VIROLOGY; VIRUS HEPATITIS;

FLAVIVIRIDAE; GB VIRUS C; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

VIRUS RNA;

EXOSOMES; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOMODULATION; LEUKOCYTES, MONONUCLEAR; RNA, VIRAL; VIRAL TROPISM;

EID: 84938350526     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.000086     Document Type: Review

References (120)

1. Adams, M. J., King, A. M. Q. & Carstens, E. B. (2013). Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013). Arch Virol 158, 2023-2030.
2. Agnello, V., Abel, G., Elfahal, M., Knight, G. B. & Zhang, Q. X. (1999). Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 96, 12766-12771.
3. Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., Ghany, M. G., Hoofnagle, J. H., Liang, T. J. & other authors (2010). Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138, 325-335.
4. Berg, T., Muller, A. R., Platz, K. P., Hohne, M., Bechstein, W. O., Hopf, U., Wiedenmann, B., Neuhaus, P. & Schreier, E. (1999). Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication. Hepatology 29, 245-249.
5. Bhanich Supapol, W., Remis, R. S., Raboud, J., Millson, M., Tappero, J., Kaul, R., Kulkarni, P., McConnell, M. S., Mock, P. A. & other authors (2009). Mother-to-child transmission of GB virus C in a HPgV tropism, persistence and immune modulation cohort of women coinfected with GB virus C and HIV in Bangkok, Thailand. J Infect Dis 200, 227-235.
6. Bhattarai, N. & Stapleton, J. T. (2012). GB virus C: the good boy virus? Trends Microbiol 20, 124-130.
7. Bhattarai, N., Rydze, R. T., Chivero, E. T. & Stapleton, J. T. (2012a). GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy. J Infect Dis 206, 1469-1472.
8. Bhattarai, N., McLinden, J. H., Xiang, J. H., Kaufman, T. M. & Stapleton, J. T. (2012b). GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways. J Immunol 189, 2211-2216
9. Bhattarai, N., McLinden, J. H., Xiang, J. H., Landay, A. L., Chivero, E. T. & Stapleton, J. T. (2013). GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling. J Immunol 190, 6351-6359
10. Bukong, T. N., Momen-Heravi, F., Kodys, K., Bala, S. & Szabo, G. (2014). Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathog 10, e1004424
11. Burke, K. P. & Cox, A. L. (2010). Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence. Immunol Res 47, 216-227.
12. Chang, C. M., Stapleton, J. T., Klinzman, D., McLinden, J. H., Purdue, M. P., Katki, H. A. & Engels, E. A. (2014). GBV-C infection and risk of NHL among U.S. adults. Cancer Res 74, 5553-5560.
13. Chivero, E. T., Bhattarai, N., Rydze, R. T., Winters, M. A., Holodniy, M. & Stapleton, J. T. (2014). Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro. J Gen Virol 95, 1307-1319
14. Civardi, G., Tanzi, E., Ferrari, B., Vallisa, D., Zanetti, A. & Cavanna, L. (1998). High prevalence of anti-HGV/E2 antibodies in HCV-positive patients with non Hodgkin’s lymphoma. Haematologica 83, 957-958
15. De Maria, A., Fogli, M., Mazza, S., Basso, M., Picciotto, A., Costa, P., Congia, S., Mingari, M. C. & Moretta, L. (2007). Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol 37, 445-455.
16. De Renzo, A., Persico, E., de Marino, F., di Giacomo Russo, G., Notaro, R., di Grazia, C., Picardi, M., Santoro, L., Torella, R. & other authors (2002). High prevalence of hepatitis G virus infection in Hodgkin’s disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection. Haematologica 87, 714-718.
17. Deinhardt, F., Holmes, A. W., Capps, R. B. & Popper, H. (1967). Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med 125, 673-688.
18. Dreux, M., Garaigorta, U., Boyd, B., Décembre, E., Chung, J., Whitten-Bauer, C., Wieland, S. & Chisari, F. V. (2012). Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12, 558-570.
19. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D. & Noelle, R. J. (1994). The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 15, 406-411.
20. Elkayam, O., Hassoba, H. M., Ferrell, L. D., Garcia-Kennedy, R., Gish, R. G., Wright, T. L., Laffler, T., Traylor, D., Hunt, G. & Rosenthal, P. (1999). GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplant. Pediatr Res 45, 795-798.
21. Ellenrieder, V., Weidenbach, H., Frickhofen, N., Michel, D., Prummer, O., Klatt, S., Bernas, O., Mertens, T., Adler, G. & Beckh, K. (1998). HCV and HGV in B-cell non-Hodgkin’s lymphoma. J Hepatol 28, 34-39
22. Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wolk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D. & Rice, C. M. (2007). Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801-805.
23. Fan, X., Xu, Y., Solomon, H., Ramrakhiani, S., Neuschwander-Tetri, B. A. & Di Bisceglie, A. M. (1999). Is hepatitis G/GB virus-C virus hepatotropic? Detection of hepatitis G/GB virus-C viral RNA in liver and serum. J Med Virol 58, 160-164.
24. Feng, Z., Hensley, L., McKnight, K. L., Hu, F., Madden, V., Ping, L., Jeong, S. H., Walker, C., Lanford, R. E. & Lemon, S. M. (2013). A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496, 367-371.
25. Fernández, L., Bleda, M. J., Gómara, M. J. & Haro, I. (2013). Design and application of GB virus C (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection. Anal Bioanal Chem 405, 3973-3982
26. Fogeda, M., Navas, S., Martín, J., Casqueiro, M., Rodríguez, E., Arocena, C. & Carreño, V. (1999). In vitro infection of human peripheral blood mononuclear cells by GB virus C/hepatitis G virus. J Virol 73, 4052-4061
27. Foy, T. M., Durie, F. H. & Noelle, R. J. (1994). The expansive role of CD40 and its ligand, gp39, in immunity. Semin Immunol 6, 259-266
28. George, S. L., Xiang, J. H. & Stapleton, J. T. (2003). Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 316, 191-201
29. George, S. L., Varmaz, D. & Stapleton, J. T. (2006). GB virus C replicates in primary T and B lymphocytes. J Infect Dis 193, 451-454
30. Giannoulis, E., Economopoulos, T., Mandraveli, K., Giannoulis, K., Nikolaides, C., Zervou, E., Papageorgiou, E., Zoulas, D., Tourkantonis, A. & other authors (2004). The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study. Acta Haematol 112, 189-193.
31. Gómara, M. J., Fernández, L., Pérez, T., Tenckhoff, S., Casanovas, A., Tillmann, H. L. & Haro, I. (2011). Diagnostic value of anti-GBV-C antibodies in HIV-infected patients. Chem Biol Drug Des 78, 277-282
32. Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J. H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M. & Walker, C. M. (2003). HCV persistence and immune evasion in the absence of memory T cell help. Science 302, 659-662.
33. Gutierrez, R. A., Dawson, G. J., Knigge, M. F., Melvin, S. L., Heynen, C. A., Kyrk, C. R., Young, C. E., Carrick, R. J., Schlauder, G. G. & other authors (1997). Seroprevalence of GB virus C and persistence of RNA and antibody. J Med Virol 53, 167-173.
34. Heringlake, S., Ockenga, J., Tillmann, H. L., Trautwein, C., Meissner, D., Stoll, M., Hunt, J., Jou, C., Solomon, N. & other authors (1998). GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 177, 1723-1726.
35. Hino, K., Moriya, T., Ohno, N., Takahashi, K., Hoshino, H., Ishiyama, N., Katayama, K., Yoshizawa, H. & Mishiro, S. (1998). Mother-to-infant transmission occurs more frequently with GB virus C than hepatitis C virus. Arch Virol 143, 65-72.
36. Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H. & Deeks, S. G. (2003). T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187, 1534-1543.
37. Kapoor, A., Simmonds, P., Scheel, T. K., Hjelle, B., Cullen, J. M., Burbelo, P. D., Chauhan, L. V., Duraisamy, R., Sanchez Leon, M. & 1529 other authors (2013). Identification of rodent homologs of hepatitis C virus and pegiviruses. MBio 4, e00216-e13.
38. Keck, Z. Y., Li, S. H., Xia, J., von Hahn, T., Balfe, P., McKeating, J. A., Witteveldt, J., Patel, A. H., Alter, H. & other authors (2009). Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity. J Virol 83, 6149-6160
39. Keck, Z. Y., Angus, A. G., Wang, W., Lau, P., Wang, Y., Gatherer, D., Patel, A. H. & Foung, S. K. (2014). Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423. PLoS Pathog 10, e1004297.
40. Keresztes, K., Takács, M., Horányi, M., Miltényi, Z. & Illés, A. (2003). HCV and HGV infection in Hodgkin’s disease. Pathol Oncol Res 9, 222-225.
41. Kirwan, S., Merriam, D., Barsby, N., McKinnon, A. & Burshtyn, D. N. (2006). Vaccinia virus modulation of natural killer cell function by direct infection. Virology 347, 75-87.
42. Kisiel, E., Cortez, K. C., Pawełczyk, A., Ośko, I. B., Kubisa, N., Laskus, T. & Radkowski, M. (2013). Hepatitis G virus/GBV-C in serum, peripheral blood mononuclear cells and bone marrow in patients with hematological malignancies. Infect Genet Evol 19, 195-199.
43. Kleinman, S. (2001). Hepatitis G virus biology, epidemiology, and clinical manifestations: implications for blood safety. Transfus Med Rev 15, 201-212.
44. Krajden, M., Yu, A., Braybrook, H., Lai, A. S., Mak, A., Chow, R., Cook, D., Tellier, R., Petric, M. & other authors (2010). GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study. Int J Cancer 126, 2885-2892
45. Laras, A., Zacharakis, G. & Hadziyannis, S. J. (1999). Absence of the negative strand of GBV-C/HGV RNA from the liver. J Hepatol 30, 383-388.
46. Laskus, T., Radkowski, M., Wang, L. F., Vargas, H. & Rakela, J. (1997). Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol 71, 7804-7806
47. Lauck, M., Bailey, A. L., Anderson, K. G., Goldberg, T. L., Sabeti, P. C. & O’Connor, D. H. (2015). GB virus C coinfections in West African Ebola patients. J Virol 89, 2425-2429
48. Leary, T. P., Muerhoff, S., Simons, J. N., Pilot-Matias, T. J., Erker, J. C., Chalmers, M. L., Schlauder, G. G., Dawson, G. J., Desai, S. M. & Mushahwar, I. K. (1996). Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 48, 60-67.
49. Lemon, S. M. (2010). Induction and evasion of innate antiviral responses by hepatitis C virus. J Biol Chem 285, 22741-22747.
50. Lin, H. H., Kao, J. H., Yeh, K. Y., Liu, D. P., Chang, M. H., Chen, P. J. & Chen, D. S. (1998). Mother-to-infant transmission of GB virus C/ hepatitis G virus: the role of high-titered maternal viremia and mode of delivery. J Infect Dis 177, 1202-1206.
51. Loureiro, C. L., Alonso, R., Pacheco, B. A., Uzcátegui, M. G., Villegas, L., León, G., De Saéz, A., Liprandi, F., López, J. L. & Pujol, F. H. (2002). High prevalence of GB virus C/hepatitis G virus genotype 3 among autochthonous Venezuelan populations. J Med Virol 68, 357-362.
52. Lozach, P. Y., Lortat-Jacob, H., de Lacroix de Lavalette, A., Staropoli, I., Foung, S., Amara, A., Houles, C., Fieschi, F., Schwartz, O. & other authors (2003). DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278, 20358-20366.
53. Maggi, F., Fornai, C., Zaccaro, L., Morrica, A., Vatteroni, M. L., Isola, P., Marchi, S., Ricchiuti, A., Pistello, M. & Bendinelli, M. (2001). TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. J Med Virol 64, 190-194.
54. Maidana-Giret, M. T., Silva, T. M., Sauer, M. M., Tomiyama, H., Levi, J. E., Bassichetto, K. C., Nishiya, A., Diaz, R. S., Sabino, E. C. & other authors (2009). GB virus type C infection modulates T-cell activation independently of HIV-1 viral load. AIDS 23, 2277-2287
55. Martin, D. N. & Uprichard, S. L. (2013). Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci U S A 110, 10777-10782.
56. Meckes, D. G., Jr & Raab-Traub, N. (2011). Microvesicles and viral infection. J Virol 85, 12844-12854.
57. Mellor, J., Haydon, G., Blair, C., Livingstone, W. & Simmonds, P. (1998). Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J Gen Virol 79, 705-714.
58. Michaelis, S., Kazakov, D. V., Schmid, M., Dummer, R., Burg, G. & Kempf, W. (2003). Hepatitis C and G viruses in B-cell lymphomas of the skin. J Cutan Pathol 30, 369-372.
59. Milush, J. M., Mir, K. D., Sundaravaradan, V., Gordon, S. N., Engram, J., Cano, C. A., Reeves, J. D., Anton, E., O’Neill, E. & other authors (2011). Lack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cells. J Clin Invest 121, 1102-1110.
60. Mohr, E. L. & Stapleton, J. T. (2009). GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat 16, 757-768.
61. Moradpour, D., Penin, F. & Rice, C. M. (2007). Replication of hepatitis C virus. Nat Rev Microbiol 5, 453-463.
62. Nakamura, S., Takagi, T. & Matsuda, T. (1997). Hepatitis G virus RNA in patients with B-cell non-Hodgkin’s lymphoma. Br J Haematol 98, 1051-1052.
63. Nattermann, J., Nischalke, H. D., Kupfer, B., Rockstroh, J., Hess, L., Sauerbruch, T. & Spengler, U. (2003). Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 17, 1457-1462
64. Nunnari, G., Nigro, L., Palermo, F., Attanasio, M., Berger, A., Doerr, H. W., Pomerantz, R. J. & Cacopardo, B. (2003). Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 139, 26-30
65. Ohto, H., Ujiie, N., Sato, A., Okamoto, H., Mayumi, M. & Vertical Transmission of Hepatitis Viruses Collaborative Study Group (2000). Mother-to-infant transmission of GB virus type C/HGV. Transfusion 40, 725-730.
66. Okamoto, H. (2009). History of discoveries and pathogenicity of TT viruses. Curr Top Microbiol Immunol 331, 1-20.
67. Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., De Filippi, F., Bruno, S. & Mondelli, M. U. (2009). Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137, 1151-1160.
68. Pavesi, A. (2001). Origin and evolution of GBV-C/hepatitis G virus and relationships with ancient human migrations. J Mol Evol 53, 104-113.
69. Peppa, D., Micco, L., Javaid, A., Kennedy, P. T. F., Schurich, A., Dunn, C., Pallant, C., Ellis, G., Khanna, P. & other authors (2010). Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 6, e1001227.
70. Pessoa, M. G., Terrault, N. A., Detmer, J., Kolberg, J., Collins, M., Hassoba, H. M. & Wright, T. L. (1998). Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 27, 877-880.
71. HPgV tropism, persistence and immune modulation Petitjean, G., Chevalier, M. F., Tibaoui, F., Didier, C., Manea, M. E., Liovat, A. S., Campa, P., Muller-Trutwin, M., Girard, P. M. & other authors (2012). Level of double negative T cells, which produce TGF-b and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection. AIDS 26, 139-148
72. Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P. & Rice, C. M. (2009). Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882-886.
73. Radkowski, M., Kubicka, J., Kisiel, E., Cianciara, J., Nowicki, M., Rakela, J. & Laskus, T. (2000). Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood 95, 3986-3989
74. Rajagopalan, S. & Long, E. O. (2000). Use of vaccinia virus for functional gene transfer in natural killer cells. Methods Mol Biol 121, 265-272.
75. Ramakrishnaiah, V., Thumann, C., Fofana, I., Habersetzer, F., Pan, Q. W., de Ruiter, P. E., Willemsen, R., Demmers, J. A. A., Stalin Raj, V. & other authors (2013). Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci U S A110,13109-13113.
76. Rehermann, B. (2013). Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 19, 859-868.
77. Ruiz, V., Giordano, M., Rivero, C. W., Minassian, M. L., Cuestas, M. L., Trinks, J., Mathet, V. L. & Oubiña, J. R. (2010). GB virus C quasispecies detected in plasma and lymphocyte subsets in a natural human infection. J Gen Virol 91, 1687-1692.
78. Rydze, R. T., Bhattarai, N. & Stapleton, J. T. (2012). GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death. Antivir Ther 17, 1271-1279.
79. Sainz, B., Jr, Barretto, N., Martin, D. N., Hiraga, N., Imamura, M., Hussain, S., Marsh, K. A., Yu, X., Chayama, K. & other authors (2012). Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18, 281-285.
80. Sánchez-Puig, J. M., Sánchez, L., Roy, G. & Blasco, R. (2004). Susceptibility of different leukocyte cell types to Vaccinia virus infection. Virol J 1, 10
81. Schwarze-Zander, C., Blackard, J. T., Zheng, H., Addo, M. M., Lin, W., Robbins, G. K., Sherman, K. E., Zdunek, D., Hess, G. & other authors (2006). GB virus C (GBV-C) infection in hepatitis C virus (HCV)/ HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis 194, 410-419.
82. Schwarze-Zander, C., Neibecker, M., Othman, S., Welzel, C., Schulz, M., Voigt, E., Vogel, M., Wasmuth, C., Luechters, G. & other authors (2007). GBV-C co-infection in HIV patients is associated with low CCR5 and CXCR4 surface expression on CD4 cells. Hepatology 46 (Suppl. S1), 891A
83. Sharp, P. M. & Simmonds, P. (2011). Evaluating the evidence for virus/host co-evolution. Curr Opin Virol 1, 436-441
84. Sibley, S. D., Lauck, M., Bailey, A. L., Hyeroba, D., Tumukunde, A., Weny, G., Chapman, C. A., O’Connor, D. H., Goldberg, T. L. & Friedrich, T. C. (2014). Discovery and characterization of distinct simian pegiviruses in three wild African Old World monkey species. PLoS One 9, e98569
85. Simmonds, P. & Smith, D. B. (1999). Structural constraints on RNA virus evolution. J Virol 73, 5787-5794
86. Simons, J. N., Leary, T. P., Dawson, G. J., Pilot-Matias, T. J., Muerhoff, A. S., Schlauder, G. G., Desai, S. M. & Mushahwar, I. K. (1995). Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1, 564-569.
87. Stapleton, J. T. (2003). GB virus type C/hepatitis G virus. Semin Liver Dis 23, 137-148
88. Stapleton, J. T., Chaloner, K., Zhang, J. Y., Klinzman, D., Souza, I. E., Xiang, J. H., Landay, A., Fahey, J., Pollard, R. & Mitsuyasu, R. (2009). GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS 23, 605-610
89. Stapleton, J. T., Foung, S., Muerhoff A. S., Bukh, J. & Simmonds, P. (2011). The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 92, 233-246.
90. Stapleton, J. T., Bukh, J., Muerhoff, A. S., Foung, S. & Simmonds, P. (2012a). Assignment of human, simian and bat pegiviruses (previously described as GBV-A, GBV-C, and GBV-D) as members of a new genus (Pegivirus) within the Flaviviridae. http://www.ictvonline.org/proposals/2012.011a-dV.A.v2.Pegivirus.pdf
91. Stapleton, J. T., Chaloner, K., Martenson, J. A., Zhang, J. Y., Klinzman, D., Xiang, J. H., Sauter, W., Desai, S. N. & Landay, A. (2012b). GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals. PLoS One 7, e50563.
92. Stapleton, J. T., Martinson, J. A., Klinzman, D., Xiang, J., Desai, S. N. & Landay, A. (2013). GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals. AIDS 27, 1829-1832
93. Stapleton, J. T., Xiang, J., McLinden, J. H., Bhattarai, N., Chivero, E. T., Klinzman, D., Kaufman, T. M. & Chang, Q. (2014). A novel T cell evasion mechanism in persistent RNA virus infection. Trans Am Clin Climatol Assoc 125, 14-24.
94. Sundaravaradan, V., Mir, K. D. & Sodora, D. L. (2012). Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup. Curr Opin HIV AIDS 7, 164-171
95. Sundaravaradan, V., Saleem, R., Micci, L., Gasper, M. A., Ortiz, A. M., Else, J., Silvestri, G., Paiardini, M., Aitchison, J. D. & Sodora, D. L. (2013). Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection. PLoS Pathog 9, e1003441.
96. Tacke, M., Schmolke, S., Schlueter, V., Sauleda, S., Esteban, J. I., Tanaka, E., Kiyosawa, K., Alter, H. J., Schmitt, U. & other authors (1997). Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 26, 1626-1633.
97. Takahashi, M., Asabe, S., Gotanda, Y., Kishimoto, J., Tsuda, F. & Okamoto, H. (2002). TT virus is distributed in various leukocyte subpopulations at distinct levels, with the highest viral load in granulocytes. Biochem Biophys Res Commun 290, 242-248.
98. Tan, D., Matsumoto, A., Conry-Cantilena, C., Melpolder, J. C., Shih, J. W. K., Leuther, M., Hess, G., Gibble, J. W., Ness, P. M. & Alter, H. J. (1999). Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. J Infect Dis 179, 1055-1061.
99. Tanaka, E., Kiyosawa, K., Shimoda, K., Hino, K., Tacke, M., Schmolke, S., Engel, A. M. & Hess, G. (1998a). Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis. J Viral Hepat 5, 153-159.
100. Tanaka, Y., Mizokami, M., Orito, E., Ohba, K., Nakano, T., Kato, T., Kondo, Y., Ding, X., Ueda, R. & other authors (1998b). GB virus C/ hepatitis G virus infection among Colombian native Indians. Am J Trop Med Hyg 59, 462-467.
101. Thomas, D. L., Nakatsuji, Y., Shih, J. W., Alter, H. J., Nelson, K. E., Astemborski, J. A., Lyles, C. M. & Vlahov, D. (1997). Persistence and clinical significance of hepatitis G virus infections in injecting drug users. J Infect Dis 176, 586-592.
102. Thomas, D. L., Vlahov, D., Alter, H. J., Hunt, J. C., Marshall, R., Astemborski, J. & Nelson, K. E. (1998). Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 177, 539-542.
103. Tillmann, H. L., Heringlake, S., Trautwein, C., Meissner, D., Nashan, B., Schlitt, H. J., Kratochvil, J., Hunt, J., Qiu, X. & other authors (1998). Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 28, 379-384.
104. Tillmann, H. L., Heiken, H., Knapik-Botor, A., Heringlake, S., Ockenga, J., Wilber, J. C., Goergen, B., Detmer, J., McMorrow, M. & other authors (2001). Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345, 715-724
105. Toyoda, H., Fukuda, Y., Hayakawa, T., Takamatsu, J. & Saito, H. (1998). Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 17, 209-213.
106. Tucker, T. J., Smuts, H. E. M., Eedes, C., Knobel, G. D., Eickhaus, P., Robson, S. C. & Kirsch, R. E. (2000). Evidence that the GBV-C/ hepatitis G virus is primarily a lymphotropic virus. J Med Virol 61, 52-58.
107. Vahidnia, F., Petersen, M., Stapleton, J. T., Rutherford, G. W., Busch, M. & Custer, B. (2012). Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease. Clin Infect Dis 55, 1012-1019.
108. Welsh, R. M. & Waggoner, S. N. (2013). NK cells controlling virus-specific T cells: rheostats for acute vs. persistent infections. Virology 435, 37-45.
109. Williams, C. F., Klinzman, D., Yamashita, T. E., Xiang, J., Polgreen, P. M., Rinaldo, C., Liu, C., Phair, J., Margolick, J. B. & other authors (2004). Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350, 981-990.
110. Wunschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N. & Stapleton, J. T. (2000). Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 74, 10055-10062.
111. Wunschmann, S., Muller, H. M., Stipp, C. S., Hemler, M. E. & Stapleton, J. T. (2006). In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs. J Infect Dis 194, 1058-1067.
112. Xiang, J. H., Klinzman, D., McLinden, J., Schmidt, W. N., LaBrecque, D. R., Gish, R. & Stapleton, J. T. (1998). Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 72, 2738-2744
113. Xiang, J., Wunschmann, S., Schmidt, W., Shao, J. & Stapleton, J. T. (2000). Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 74, 9125-9133
114. Xiang, J. H., Wunschmann, S., Diekema, D. J., Klinzman, D., Patrick, K. D., George, S. L. & Stapleton, J. T. (2001). Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345, 707-714.
115. Xiang, J. H., George, S. L., Wunschmann, S., Chang, Q., Klinzman, D. & Stapleton, J. T. (2004). Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1a, MIP-1b, and SDF-1. Lancet 363, 2040-2046.
116. Zeisel, M. B., Felmlee, D. J. & Baumert, T. F. (2013). Hepatitis C virus entry. Curr Top Microbiol Immunol 369, 87-112.
117. Zhang, W., Chaloner, K., Tillmann, H. L., Williams, C. F. & Stapleton, J. T. (2006). Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med 7, 173-180.
118. Zhong, S., Yeo, W., Tang, M., Liu, C. L., Lin, X. R., Ho, W. M., Hui, P. & Johnson, P. J. (2002). Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients. J Med Virol 66, 428-434.
119. Zhu, T., Korber, B. T., Nahmias, A. J., Hooper, E., Sharp, P. M. & Ho, D. D. (1998). An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 391, 594-597.
120. Zona, L., Tawar, R. G., Zeisel, M. B., Xiao, F., Schuster, C., Lupberger, J. & Baumert, T. F. (2014). CD81-receptor associations-impact for hepatitis C virus entry and antiviral therapies. Viruses 6, 875-892